PharmaMar’s lurbinectedin misses in platinum-resistant ovarian cancer
Some brief notes on lurbinectedin in ovarian cancer and small-cell lung cancer (SCLC)… and a warning!
To learn more and get a heads up on our thought leader interview, subscribers can log-in or you can click to gain access to BSB Premium Content.
This content is restricted to subscribers